Aurigene and Orion Corporation Announce Research, Collaboration and Option Agreement for Rights to Aurigene’s Epigenetics Program for Pan BET and Selective BET Bromodomain Inhibitors

ESPOO, Finland and BANGALORE, India, June 24, 2014 /PRNewswire/ — Orion Corporation, a globally operating Finnish pharmaceuticals company and Aurigene, a leading biotech company based in India, today announced that